Inspira Technologies OXY B.H.N. Ltd

Inspira Technologies Oxy B.H.N. Ltd. is an Israeli specialty medical device company focused on life support systems for acute respiratory failure treatment. The company's primary product is the INSPIRA ART100, a cardiopulmonary bypass system designed for procedures lasting six hours or less. The device addresses clinical needs in extracorporeal life support applications where temporary circulatory and respiratory assistance is required.

The company operates in the surgical and medical instruments sector and maintains manufacturing and development capabilities in Israel. With 38 full-time employees, Inspira Technologies operates at a relatively early commercial stage. The company was incorporated in 2018 and rebranded from its former entity, Insense Medical Ltd., in July 2020 to reflect its strategic focus on oxygenation and respiratory support technologies.

Inspira Technologies is publicly traded on Nasdaq, providing access to capital markets. The company's operations remain centered in Ra'anana, Israel, where it conducts research, development, and manufacturing of its proprietary life support technology.